Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...
US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...
Aging is undoubtedly a natural part of life, and while some embrace what time does to their skin, others might look for a little something to smooth out those effects. One popular item that shoppers ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the U.S. suffer from CSU that is inadequately controlled by ...
The Committee discusses and makes recommendations for AstraZeneca (AZN) supplemental Biologics License Application (sBLA) 125586/546 for ...
A search for a solution to the crisis in Haiti is growing more urgent as gangs gain territory and thousands more flee their homes. By Frances Robles With two months left in office, the president ...
Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...
Why the iPhone SE 4 Could Be One of Apple's Most Important Products of 2025 ...
Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback